Trial NCT04579133

View at ClinicalTrials.gov 
Org. Study IDs: LACOG 0219

Last trial update was posted on 2021-06-16

MeSH Interventions

Durvalumab Olaparib

MeSH Conditions

Carcinoma Carcinoma, Transitional Cell Urinary Bladder Neoplasms

Other Conditions

Bladder Cancer Urothelial Carcinoma

Stopping Reasons

Not approved

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID